Forms Processing

WHITE PAPERS AND CASE STUDIES

• How Can Digital Measures Advance Heart Failure Research?

  Wearable DHTs offer a less burdensome means of collecting data on physical activity, mobility, and sleep patterns, all of which are crucial indicators in heart failure management.

• The EMR Interoperability Dream Vs. Clinical Research Reality

  Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.

• Using Virtual Study Coordinators For EDC Entry And Query Resolution To Speed Up Data Access And Cleaning

  The piece showcases how the effective use of CRIO can significantly enhance site performance, supporting recruitment and diversity objectives for sponsors.

• 3 Utilities Turning Wastewater Into Opportunity With Advanced Treatment And Reuse

  Read about three of the most pressing wastewater challenges utilities face today and how Stratmoor Hills, Key West Resort Utilities, and Beijing Water Group are using advanced treatment and reuse to overcome them.

• Development And Regulation Of Veterinary Monoclonals

  Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.

• How To Get Products To Patients Faster With A Connected QMS

  BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.

• Closing The Gap In Our Understanding Of Sleep Health With DHTs

  What is the current state of sleep assessments in clinical trials, regulatory expectations, and what opportunities do wearable digital health technologies present?

• Membrane Filter Pore Size Impact On Colony Size, Microbial Recovery

  Explore results from a study evaluating the effects of different pore sizes on colony size and microbial recovery using membrane filters.

• Agentic AI And How It's Impacting Clinical Trial Research

  Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.

• Improving The Advanced Therapies Digital Landscape

  Discover how ProPharma transformed a rapidly growing biotech company's data governance and systems architecture to enhance efficiency and data integrity.

• A Risk-Based Approach To Plasmid DNA And mRNA Process Development

  Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

• Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies

  Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.